Ming Y. Lim
( out of 129 reviews )

Ming Y. Lim, MBBCh, MS

Languages spoken: English

Clinical Locations

Sugar House Health Center

801-581-2000

  • Dr. Ming Y. Lim is an Associate Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah. She earned her medical degree at Cambridge University, England and completed her 2-year Foundation Training in the United Kingdom. She then completed residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at University of North Carolina at Chapel Hill. Her clinical interest lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting people with congenital bleeding disorders, specifically persons with hemophilia with inhibitors and pregnant women with bleeding disorders.

    Dr. Lim is the Medical Director for the Utah Center for Bleeding & Clotting Disorders at University of Utah Health. Nationally, she serves on the American Board of Internal Medicine Hematology Approval Committee and is the Chair of the American Society of Hematology Subcommittee on Stewardship and Systems-Based Hematology. She also serves on the National Comprehensive Cancer Network (NCCN) Cancer-Associated Venous Thromboembolic Disease Panel.

    Specialties

    Board Certification

    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    Educational Commission for Foreign Medical Graduates

    Patient Rating

    4.8 /5
    ( out of 129 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    September 19, 2023
    SUGAR HOUSE HEALTH CENTER

    Very professional. Seems very competent and professional to me. Excellent!

    September 15, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr. Lim came into the room prepared to discuss everything with me. She had all the answers to my questions without having to look at my chart because she had clearly spent time on that before my appointment. I felt like my care really mattered to her. I felt like a person, not just a patient.

    July 27, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr. Lim was able to help me understand my new diagnosis (which was rather confusing to me) in a way that was simple and to the point. She provided me with a detailed plan of care and made me feel hopeful for how I'm going to be feeling in the future.

    July 11, 2023
    SUGAR HOUSE HEALTH CENTER

    Ming Lim its a great doctor

    July 11, 2023
    SUGAR HOUSE HEALTH CENTER

    I trust Dr. Lim By far, she has been the most honest and thoughtful, upfront specialist I see. She is a God send.

    April 26, 2023
    SUGAR HOUSE HEALTH CENTER

    She's kind and explains everything in detail so myself and my spouse can understand the steps and precautions I need to take.

    April 19, 2023
    SUGAR HOUSE HEALTH CENTER

    Ella me atendi bien

    April 19, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr Lim is very empathetic and knowledgeable. I believe she will help identify my bleeding problems.

    March 06, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr. Lim is amazing!

    See More Patient Comments

  • Dr. Ming Y. Lim is an Associate Professor in the Division of Hematology and Hematologic Malignancies at the University of Utah. She earned her medical degree at Cambridge University, England and completed her 2-year Foundation Training in the United Kingdom. She then completed residency in internal medicine at the Mayo Clinic Rochester and fellowship training in hematology and oncology at University of North Carolina at Chapel Hill. Her clinical interest lies in the field of hemostasis and thrombosis. Her research interest is focused on complications affecting people with congenital bleeding disorders, specifically persons with hemophilia with inhibitors and pregnant women with bleeding disorders.

    Dr. Lim is the Medical Director for the Utah Center for Bleeding & Clotting Disorders at University of Utah Health. Nationally, she serves on the American Board of Internal Medicine Hematology Approval Committee and is the Chair of the American Society of Hematology Subcommittee on Stewardship and Systems-Based Hematology. She also serves on the National Comprehensive Cancer Network (NCCN) Cancer-Associated Venous Thromboembolic Disease Panel.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Board Certification
    American Board of Internal Medicine (Internal Medicine)
    American Board of Internal Medicine (Sub: Hematology)
    American Board of Internal Medicine (Sub: Medical Oncology)
    Educational Commission for Foreign Medical Graduates

    Education history

    Graduate Training Clinical Research - Medical University of South Carolina M.S.
    Hematology/Oncology - University of North Carolina at Chapel Hill School of Medicine Fellow
    Residency Internal Medicine - Mayo School of Graduate Medical Education Resident
    Palliative Medicine - Cardiff University School of Medicine Diploma
    Professional Medical Clinical Medicine - Cambridge University School of Clinical Medicine MB BChir
    Medical Sciences - Magdalene College, University of Cambridge M.A.

    Selected Publications

    Journal Article

    1. Chaturvedi S, Antun AG, Farland AM, Woods R, Metjian A, Park YA, de Ridder G, Gibson B, Kasthuri RS, Liles DK, Akwaa F, Clover T, Baumann Kreuziger L, Sadler JE, Sridharan M, Go RS, McCrae KR, Upreti HV, Liu A, Lim MY, Gangaraju R, Zheng XL, Raval JS, Masias C, Cataland SR, Johnson A, Davis E, Evans MD, Mazepa MA, United States Thrombotic Microangiopathies Consortium (2022). Race, Rituximab, and Relapse in TTP. Blood, 140(12), 1335-1344.

    Case Report

    1. Gleichgerrcht E, Lim MY, Turan TN (2017). Cerebral Venous Sinus Thrombosis Due to Low-molecular-weight Heparin-induced Thrombocytopenia. Neurologist, 22(6), 241-244.